EN DE
Watch Acuren Corporation for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Acuren Corporation (TIC) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Acuren Corporation stock $7.45, price $10.37, that is 28.2% below the price, quality 34 out of 100. Rating: overvalued. Calculated from audited financials with 8 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials US

AC Acuren Corporation logo Some data Nov 9, 2026

Acuren Corporation

TIC · US
Expensive, weak quality

Our calculation puts a fair price 28% below what the stock costs today.

Generates free cash flow
Revenue last quarter +35% vs. a year ago.
Mixed Growth (revenue 3y +18.1 %/yr in USD)
Moderate debt
Some data
Fair value $7.45 · Overvalued
Quality 34/100
Loss-making · -5.1% net margin (TTM)
Trails peers (2/11)
Narrow moat 20/100
Watch Acuren Corporation for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$14.49 $6.54 Fair Value $7.45 Feb 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

21‑month range $6.54 – $14.49 · fair‑value band $2.49 – $16.35 · the $10.37 price screens above the $7.45 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.

Follow Acuren in your weekly email

Every Wednesday you see whether Acuren is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

TIC Solutions, Inc. provides critical asset integrity services in North America.

Show moreShow less

The company offers testing, inspection, certification, and compliance (TICC) services, including various nondestructive testing (NDT) techniques, such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection.

Its NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, prevent costly outages, failures, and accidents, and meet regulatory requirements without damaging the asset or component.

It also provides market rope access technician solutions, including inspection and testing, as well as insulation, coatings and blasting, welding, pipe fitting, hoisting and rigging, and electrical services.

In addition, its TICC services include support from consulting engineers with destructive testing, support failure investigation, material selection, corrosion engineering, welding engineering, fracture mechanics, destructive testing, and chemical analysis.

Further, it offers geospatial services, such as data collection, data analytics, and software solutions that support asset management and infrastructure planning.

The company serves a range of industrial markets, such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper.

TIC Solutions, Inc. was formerly known as Acuren Corporation and changed its name to TIC Solutions, Inc. in October 2025. The company was founded in 1974 and is headquartered in Hollywood, Florida.

Stock analysis

Acuren Corporation (TIC) currently trades at $10.37, while our model-based Fair Value estimate is $7.45, 28% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of $9.35 per share, and 0 of the 7 models we run sit above the $10.37 price.

Bear case: the Multiples group reads lowest at $5.30, and 7 of the 7 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $2.49 (bear) to $16.35 (bull), the price of $10.37 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 34/100 (below-average quality), in the Industrials sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Acuren Corporation reported revenue of $1.5B in FY2025 versus $928M in FY2022, a compound +18.1%/yr. Reported net income was −$87.1M in FY2025.

Key figures

Market cap $2.3B Mid · P/S ratio 1.02 · EPS (TTM) $−0.6100 · Net margin −5.1% · Return on equity −5.6% · Return on assets (EBIT) 1.3% (4-year average) · Operating margin 2.5% · Revenue (TTM) $2.2B.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 20 out of 100 (medium confidence).

What moves the price

The share trades about 11% below its 52-week high and 59% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −12% fair-value upside, at −28%, TIC screens richer than that median.

Fair Value models

Bear $2.49 Fair Value $7.45 Bull $16.35
Price $10.37 · Downside -28.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Growth DCF $2.11 $7.45 $16.35 68
FCF DCF $2.49 $6.75 $17.62 67
Rev-Margin DCF n/a n/a $0.4700 66
All 8 models by family
DCF Models
FCF DCF $2.49 $6.75 $17.62 67
Owner Earnings $1.99 $9.35 $22.59 64
5Y EBITDA Exit $2.62 $9.39 $21.20 64
10Y Revenue Exit n/a $1.17 $2.74 61
10Y EBITDA Exit $2.45 $9.49 $21.93 58
Multiples
EV/EBITDA $2.51 $5.30 $8.08 64
Growth DCF
Growth DCF $2.11 $7.45 $16.35 68
Rev-Margin DCF n/a n/a $0.4700 66

Open the full fair value analysis →

Quality Score breakdown

Overall quality 34/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 10
How much profit the company makes from its sales and capital
Quality Growth 73
Are margins and returns getting better?
Cashflow 37
Do the profits arrive as real cash?
Financial strength 34
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 11
How calm the share price moves, does not count
Price momentum 31
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 47
Distance to the 52-week high, does not count
New shares 40
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+39.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.7% (2022) → 0.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+30.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+11.5%
Yearly sales growth analysts expect, extended to five years.
The revenue jump in 2026 (+45.0%) comes with 38% more shares (acquisition or merger paid in stock). Per share it is about +4.7%. The comparison above is unreliable in such a year.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +27.2% a year for the price and +8.9% for the forecasts.
Forecast 2026 (sales)+45.0%
Forecast 2027 (sales)+5.0%
Projected 2028 (sales)+4.6%
Projected 2029 (sales)+4.2%
Projected 2030 (sales)+3.9%

TIC screens overvalued: fair value 28% below the price. Compare with Cintas Corporation →

Compare Acuren Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 229 stocks

Beats the industry median on 2/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 34 · Bottom 25%
Fair Value upside −28.2% · Below median
Profitability
Return on assets −2.0% · Bottom 25%
Net margin (12 months) −5.1% · Bottom 25%
Operating margin (12 months) 2.5% · Below median
Growth and dividend
Revenue growth (quarter YoY) 35.0% · Top 25%
Balance sheet
Debt / equity 0.73× · Highest 25%

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 1.04× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 1.02× · Cheaper than median
Price / free cash flow (fiscal year) 36.9× · Priciest 25%
EV/EBITDA 12.3× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 45
FUTURE (revenue growth)100 · sector 33
PAST (return on equity)0 · sector 38
HEALTH (low debt)64 · sector 94
DIVIDEND (yield)0 · sector 57

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Copart, Inc CPRT $31.95 $35.15 +10% vs TIC
RB Global, Inc RBA C$131.85 C$145.04 +10% vs TIC
Wolters Kluwer N.V WKL €90.08 €98.05 +9% vs TIC
Global Payments Inc GPN $97.40 $87.83 −10% vs TIC
Brambles Limited BXB A$21.79 A$19.10 −12% vs TIC
Cintas Corporation CTAS $222.36 $188.90 −15% vs TIC
Rentokil Initial plc RTO $23.61 $19.63 −17% vs TIC
Thomson Reuters Corporation TRI $112.57 $70.75 −37% vs TIC
Aramark ARMK $52.54 $23.04 −56% vs TIC
UL Solutions Inc ULS $78.65 $33.46 −57% vs TIC

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Acuren Corporation: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Acuren Corporation Fair Value". https://www.fairvalue-calculator.com/stock/TIC

Frequently asked questions

Is Acuren Corporation (TIC) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of $7.45 versus a price of $10.37, about 28% lower (overvalued).
What is the fair value of TIC?
Our model-based fair value for Acuren Corporation is $7.45 (as of Nov 9, 2026), built from audited fundamentals. The current price: $10.37.
What is the quality score of TIC?
Acuren Corporation has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Acuren Corporation (TIC)?
Our model-based price target is the fair value of $7.45 (as of Nov 9, 2026) from 8 valuation models. Cautious scenario $2.49, optimistic scenario $16.35. It is a calculation from audited fundamentals, not an analyst target.
What is the Acuren Corporation stock forecast for 2026?
Our models put fair value at $7.45, about 28% lower versus a price of $10.37 (overvalued). Cautious scenario $2.49, optimistic scenario $16.35. The calculation is refreshed regularly with new filings.
What is the revenue of Acuren Corporation (TIC)?
Acuren Corporation reported trailing-twelve-month revenue of about $2.2B (latest available figure, as of Nov 9, 2026).
What growth is priced into Acuren Corporation (TIC)?
For today's price to be fair in a discounted-cash-flow model, Acuren Corporation would have to grow free cash flow by +30.3 % per year for five years (discount rate 11.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +18.1 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of TIC use?
Our models discount Acuren Corporation at 11.5 %: a base by market capitalisation (mid), damped by beta 1.72, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Acuren Corporation that is +30.3 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.5 %) and the same formula as our fair value.
How much growth has Acuren Corporation (TIC) delivered so far?
Over the past 3 years revenue at Acuren Corporation grew +18.1 % a year. The price currently implies free-cash-flow growth of +30.3 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Acuren Corporation (TIC) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Acuren Corporation (+30.3 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Acuren Corporation (TIC)?
The free-cash-flow yield on the price is 3.75 %: that much free cash flow Acuren Corporation produces per unit of market value. When it exceeds the discount rate of our models (11.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Acuren Corporation (TIC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Acuren Corporation it is $7.45 per share (as of Nov 9, 2026), against a price of $10.37. It is the blended result of 8 valuation models in 3 families (DCF Models, Multiples, Growth DCF).
Is Acuren Corporation stock overvalued or undervalued in 2026?
As of Nov 9, 2026, TIC trades above its calculated fair value: price $10.37, fair value $7.45, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TIC?
No. The price is what the market pays today ($10.37); the fair value is what the company's own numbers justify ($7.45). For Acuren Corporation the two are $2.92 per share apart. That gap is exactly why we show both numbers side by side.
How much is Acuren Corporation worth?
The market values Acuren Corporation at about $2.3B (market capitalisation, as of Nov 9, 2026). Per share that is $10.37; our models calculate a fair value of $7.45 per share.
What do the bullish and bearish scenarios say about TIC?
Our models span a range for Acuren Corporation: cautious scenario $2.49, base $7.45, optimistic $16.35 per share (as of Nov 9, 2026, price $10.37). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Acuren Corporation (TIC)?
Balance-sheet figures for Acuren Corporation (as of Nov 9, 2026): return on equity −5.6%, debt of 0.73 per unit of equity. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is TIC from its 52-week high?
Acuren Corporation trades at $10.37, about 11% below its 52-week high of $11.64 and 59% above the low of $6.54 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $7.45 is for.
Which stocks are comparable to Acuren Corporation?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Acuren Corporation stock attractive at the current price?
The data as of Nov 9, 2026: price $10.37, calculated fair value $7.45 (−28%), Quality Score 34/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TIC calculated?
We run Acuren Corporation through 8 models from 3 families: DCF Models, Multiples, Growth DCF. Every model gets the same audited fundamentals; the fair value of $7.45 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Acuren Corporation itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Acuren Corporation (TIC)?
The closing price on Nov 6, 2026 was $10.37. Our model-based fair value is $7.45, about 28% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Acuren Corporation right now?
Weak quality (34/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide ($2.49 to $16.35). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Key figures of Acuren Corporation

How large is the market capitalisation of Acuren Corporation (TIC)?
The market capitalisation of Acuren Corporation is $2.3B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Acuren Corporation (TIC)?
The price-to-sales ratio of Acuren Corporation is 1.02 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Acuren Corporation (TIC)?
Earnings per share at Acuren Corporation are $−0.6100. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Acuren Corporation (TIC)?
The net margin of Acuren Corporation is −5.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Acuren Corporation (TIC)?
The return on equity (ROE) of Acuren Corporation is −5.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Acuren Corporation (TIC)?
On an EBIT basis the return on assets of Acuren Corporation is 1.3% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Acuren Corporation (TIC)?
The operating margin of Acuren Corporation is 2.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Acuren Corporation (TIC)?
Revenue at Acuren Corporation is growing +35.0% versus a year earlier (3y avg +18.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Acuren Corporation (TIC) carry?
The net debt of Acuren Corporation is $1.3B (fiscal year 2025, ≈ 20.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Acuren Corporation in the live analysis

One click puts Acuren Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.